The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis

被引:165
作者
Kim, H
Muller, WJ [1 ]
机构
[1] McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada
[2] McMaster Univ, Dept Med Sci, Hamilton, ON L8S 4K1, Canada
[3] McMaster Univ, Dept Pathol, Hamilton, ON L8S 4K1, Canada
基金
英国医学研究理事会;
关键词
transgenic; epidermal growth factor receptor; erbB2; neu; mammary; tumorigenesis;
D O I
10.1006/excr.1999.4706
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A number of receptor systems have been implicated to play an important role in the development and progression of many human cancers. The epidermal growth factor (EGF) receptor tyrosine kinase family has been found to consistently play a leading role in tumor progression Indeed, in human breast cancer cases the prognosis of a patient is inversely correlated with the overexpression and/or amplification of this receptor family. Furthermore, downstream signaling components such as the Src kinases, PI3'K, and the Ras pathway display evidence of deregulation that can accelerate tumor progression. The transgenic mouse system has been ideal in elucidating the biological significance of this receptor family in mammary tumorigenesis. Molecular events involved in mammary tumorigenesis such as ligand binding, receptor dimerization, and the activation of downstream pathways have been addressed using this system. Although there are many molecular steps that appear to drive each stage of tumor development, the EGF receptor family appears to play a causal role in the progression to a transformed phenotype. (C) 1999 Academic Press.
引用
收藏
页码:78 / 87
页数:10
相关论文
共 115 条
[31]   Signal transduction - Akt signaling: Linking membrane events to life and death decisions [J].
Hemmings, BA .
SCIENCE, 1997, 275 (5300) :628-630
[32]   Think globally, act locally: the making of a mouse mammary gland [J].
Hennighausen, L ;
Robinson, GW .
GENES & DEVELOPMENT, 1998, 12 (04) :449-455
[33]   Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer [J].
Houston, SJ ;
Plunkett, TA ;
Barnes, DM ;
Smith, P ;
Rubens, RD ;
Miles, DW .
BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) :1220-1226
[34]   P185HER2 MONOCLONAL-ANTIBODY HAS ANTIPROLIFERATIVE EFFECTS INVITRO AND SENSITIZES HUMAN-BREAST TUMOR-CELLS TO TUMOR NECROSIS FACTOR [J].
HUDZIAK, RM ;
LEWIS, GD ;
WINGET, M ;
FENDLY, BM ;
SHEPARD, HM ;
ULLRICH, A .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (03) :1165-1172
[35]   THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER [J].
HYNES, NE ;
STERN, DF .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3) :165-184
[36]   TGF-ALPHA OVEREXPRESSION IN TRANSGENIC MICE INDUCES LIVER NEOPLASIA AND ABNORMAL-DEVELOPMENT OF THE MAMMARY-GLAND AND PANCREAS [J].
JHAPPAN, C ;
STAHLE, C ;
HARKINS, RN ;
FAUSTO, N ;
SMITH, GH ;
MERLINO, GT .
CELL, 1990, 61 (06) :1137-1146
[37]   ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer [J].
Karunagaran, D ;
Tzahar, E ;
Beerli, RR ;
Chen, XM ;
GrausPorta, D ;
Ratzkin, BJ ;
Seger, R ;
Hynes, NE ;
Yarden, Y .
EMBO JOURNAL, 1996, 15 (02) :254-264
[38]  
Kenney NJ, 1996, MOL CARCINOGEN, V15, P44
[39]   The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors [J].
Klapper, LN ;
Glathe, S ;
Vaisman, N ;
Hynes, NE ;
Andrews, GC ;
Sela, M ;
Yarden, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (09) :4995-5000
[40]   SYNERGISTIC INTERACTION OF P185C-NEU AND THE EGF RECEPTOR LEADS TO TRANSFORMATION OF RODENT FIBROBLASTS [J].
KOKAI, Y ;
MYERS, JN ;
WADA, T ;
BROWN, VI ;
LEVEA, CM ;
DAVIS, JG ;
DOBASHI, K ;
GREENE, MI .
CELL, 1989, 58 (02) :287-292